Fresh Competitors

Delisted . USA . 
Stock . Fresh Tracks Therapeutics
FRTXDelisted Stock  USD 0.78  0.09  10.34%   
Fresh Tracks Therapeutics competes with Assembly Biosciences, Instil Bio, Nuvation Bio, Achilles Therapeutics, and NextCure; as well as few others. The company conducts business under Biotechnology sector and is part of Health Care industry. Analyzing Fresh Tracks competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of Fresh Tracks to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.
You can use the Comparative Equity Analysis module to analyze the advantages of investing in your portfolio's related equities across multiple sectors and thematic ideas. Please use the input box below to enter symbols for particular investments you would like to analyze. With the equity comparison module, you can estimate the relative effect of Fresh Tracks competition on your existing holdings.
  
Specify up to 10 symbols:
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Fresh Tracks' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
0.780.780.78
Details
Intrinsic
Valuation
LowRealHigh
0.640.640.86
Details

Fresh Tracks Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Fresh Tracks and its competitors represents the degree of relationship between the price movements of corresponding pink sheets. A correlation of about +1.0 implies that the price of Fresh and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Fresh Tracks Therapeutics does not affect the price movement of the other competitor.
Click cells to compare fundamentals   Check Volatility   Backtest Portfolio
High positive correlations   
CMRA
+ 0.82
NUVB
UNCY
+ 0.64
ACHL
PCSA
+ 0.62
NXTC
UNCY
+ 0.54
SABS
THRD
+ 0.43
TIL
UNCY
+ 0.42
THRD
  
High negative correlations   
UNCY
- 0.7
PCSA
CMRA
- 0.68
ACHL
UNCY
- 0.64
NXTC
ACHL
- 0.62
NUVB
PCSA
- 0.6
ACHL
NXTC
- 0.55
ACHL

Risk-Adjusted Indicators

There is a big difference between Fresh Pink Sheet performing well and Fresh Tracks Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Fresh Tracks' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
ASMB  2.95  0.10  0.00  0.47  4.39 
(2.92)
 8.79 
(5.34)
 21.34 
TIL  9.58  1.71  0.27  0.47  6.82 
(12.82)
 20.63 
(10.89)
 105.83 
NUVB  3.61 (0.44)(0.02) 0.00  4.52 
(3.86)
 9.48 
(8.36)
 21.30 
ACHL  2.02  0.45  0.20  0.44  1.53 
(3.19)
 3.06 
(2.88)
 38.16 
NXTC  2.58 (0.37) 0.00  1.76  0.00 
 0.00 
 5.22 
(6.37)
 21.68 
CMRA  5.99 (0.20) 0.00 (0.01) 0.00 
 0.00 
 13.95 
(12.70)
 30.28 
SABS  5.56  0.48  0.06  1.32  6.18 
(6.45)
 17.06 
(11.25)
 45.73 
PCSA  2.77 (0.67) 0.00 (0.41) 0.00 
 0.00 
 6.20 
(5.34)
 20.99 
THRD  3.39 (0.10) 0.01  0.08  4.83 
(3.30)
 8.35 
(6.74)
 25.76 
UNCY  4.28  0.93  0.17  0.69  4.33 
(5.53)
 10.26 
(7.41)
 29.22 
All Fundamental Data

Fresh Tracks Competitive Analysis

The better you understand Fresh Tracks competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Fresh Tracks' competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Fresh Tracks' competition over several years is one of the best ways to analyze its investment potential.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
FRTX ASMB TIL NUVB ACHL NXTC CMRA SABS PCSA THRD
 10.34 
 0.78 
Fresh
 1.90 
 17.15 
Assembly
 0.00 
 26.40 
Instil
 3.21 
 2.89 
Nuvation
 0.94 
 1.07 
Achilles
 2.50 
 1.17 
NextCure
 1.54 
 0.66 
Comera
 0.67 
 2.95 
SAB
 3.92 
 0.98 
Processa
 1.30 
 12.94 
Third
Market Volatility
(90 Days Market Risk)
Very steady
Relatively risky
Unstable
Risky
Very risky
Risky
Very steady
Dangerous
Dangerous
Moderately volatile
Market Performance
(90 Days Performance)
Very Weak
Insignificant
OK
Weak
Good
Very Weak
Very Weak
Insignificant
Very Weak
Insignificant
Odds of Financial Distress
(Probability Of Bankruptcy)
Dangerous
Low
Average
About Average
Below Average
Above Average
Dangerous
About Average
Very High
Low
Current Valuation
(Equity Enterprise Value)
Over Valued
Over Valued
Over Valued
Under Valued
Under Valued
Under Valued
Over Valued
Over Valued
Under Valued
Over Valued
Buy or Sell Advice
(Average Analysts Consensus)
Not Available
Strong Buy
Buy
Strong Buy
Buy
Buy
Not Available
Strong Buy
Buy
Strong Buy
Trade Advice
(90 Days Macroaxis Advice)
Not Rated
Strong Sell
Hold
Strong Sell
Strong Buy
Strong Sell
Not Rated
Strong Sell
Strong Sell
Strong Sell
Current Ratio
6.36
8.31
8.51
33.58
11.45
33.87
2.14
1.72
8.89
23.59
Net Asset
10.27 M
136.82 M
325.63 M
621.48 M
161.46 M
128.04 M
3.73 M
83.94 M
5.79 M
277.71 M
Profit Margin
-0.89
-2.12
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
EBITDA
(21.09 M)
(64.2 M)
(146.12 M)
(99.6 M)
(70.44 M)
(59.04 M)
(13.33 M)
(38.08 M)
(11.46 M)
(30.79 M)
Operating Margin
0.25
-1.43
N/A
-66.16
N/A
N/A
-15.82
-34.23
N/A
N/A
Current Valuation
(4.04 M)
13.46 M
158.81 M
434.73 M
(36.74 M)
(37.15 M)
9.96 M
1.35 M
407.31 K
298.03 M
Price To Book
0.45
4.11
1.1
1.93
0.43
0.43
N/A
0.74
0.86
2.0
Retained Earnings
(166.47 M)
(785.75 M)
(580.98 M)
(342.8 M)
(259.95 M)
(324.48 M)
(34.9 M)
(90.06 M)
(75.37 M)
(114.22 M)
Current Asset
N/A
68.37 M
N/A
N/A
N/A
46.99 M
N/A
N/A
N/A
N/A
Five Year Return
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
One Year Return
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Beta
0.47
0.59
1.74
1.36
1.34
0.79
1.16
0.64
0.6
2.86
Number Of Employees
13
65
49
203
204
82
12
57
13
51
Shares Outstanding
5.97 M
6.36 M
6.53 M
335.57 M
41.09 M
28.01 M
30.74 M
9.23 M
3.27 M
45.06 M
Three Year Return
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash Flow From Operations
(19.34 M)
22.74 M
(82.03 M)
(68 M)
(48.45 M)
(52.97 M)
(9.77 M)
(25.12 M)
(8.06 M)
(20.43 M)
Annual Yield
0.0134
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Debt
49 K
2.34 M
86.05 M
4.01 M
4.62 M
6.61 M
775.05 K
5.91 M
150.55 K
3.95 M
Return On Equity
-0.81
-1.02
-0.49
-0.96
-0.44
-0.55
-16.29
-1.75
-2.12
-0.14
Z Score
31.28
N/A
N/A
N/A
N/A
N/A
-20.09
N/A
N/A
N/A
Return On Asset
-0.42
-0.35
-0.12
-0.14
-0.27
-0.31
-1.19
-0.79
-1.13
-0.11
Number Of Shares Shorted
50.18 K
11.54 K
303.2 K
10.97 M
215.69 K
44.86 K
281.55 K
39.93 K
73.06 K
3.13 M
Book Value Per Share
1.85
7.5
34.72
1.5
3.47
4.1
-0.14
4.0
1.14
6.59
Current Liabilities
N/A
3.4 M
N/A
N/A
N/A
5.53 M
N/A
N/A
N/A
N/A
Total Asset
10.27 M
136.82 M
325.63 M
621.48 M
161.46 M
128.04 M
3.73 M
83.94 M
5.79 M
277.71 M
Debt To Equity
0.002
0.041
0.12
0.006
0.043
0.01
0.16
0.16
0.001
7.81
Short Ratio
0.69
0.41
2.29
5.67
1.69
1.89
0.84
0.29
2.42
17.82
Target Price
4.5
35.5
100.33
6.5
4.0
3.33
N/A
12.4
6.0
19.0
Shares Owned By Institutions
8.96
18.79
80.7
56.34
59.29
57.5
2.7
34.24
1.48
92.4
Market Capitalization
4.84 M
106.98 M
193.82 M
972.68 M
45.71 M
32.77 M
6.85 M
27.23 M
3.2 M
590.72 M
Price To Earning
N/A
-10.58
18.31
N/A
0.49
-25.44
N/A
N/A
N/A
23.13
Price To Earnings To Growth
N/A
N/A
N/A
N/A
-0.31
0.03
N/A
N/A
-0.12
N/A
Price To Sales
0.48
4.98
55329.79
449.9
N/A
9.52
43.28
18.0
N/A
N/A
Net Income
(21.1 M)
(61.23 M)
(156.09 M)
(75.8 M)
(69.94 M)
(62.72 M)
(18 M)
(42.19 M)
(11.12 M)
(30.82 M)
Earnings Per Share
-2.32
-6.89
-11.56
-2.18
-1.66
-2.1
-0.22
-6.3
-4.8
-0.97
Shares Owned By Insiders
11.62
31.62
12.86
26.85
6.51
8.85
51.33
19.15
8.74
9.04
Revenue
6.94 M
7.16 M
N/A
N/A
N/A
N/A
633.1 K
2.24 M
N/A
N/A
Working Capital
7.01 M
94.56 M
150.2 M
602.46 M
128.64 M
105.84 M
(2 M)
48.09 M
4.9 M
267.03 M
Ten Year Return
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash And Equivalents
14.48 M
116.69 M
354.61 M
703.8 M
201.6 M
185.49 M
4.94 M
16.62 M
12.06 M
112.73 M
Cash Per Share
5.04
2.41
2.73
3.22
4.94
6.68
0.26
0.39
0.76
25.53
Gross Profit
(27.83 M)
(63.9 M)
138 K
N/A
N/A
(54.2 M)
422.71 K
(12.53 M)
N/A
N/A
Day Typical Price
0.81
16.55
27.46
2.91
1.06
1.19
0.65
2.98
0.99
13.1
Accumulation Distribution
0.14
0.1
0.16
0.0237
0.037
0.0569
0.0896
0.0895
0.0392
0.0517
Market Facilitation Index
0.12
1.8
4.92
0.07
0.04
0.07
0.06
0.28
0.04
0.7
Daily Balance Of Power
(0.75)
0.1778
N/A
1.285714
0.25
(0.43)
0.1667
(0.07)
(1.00)
(0.24)
Period Momentum Indicator
(0.09)
0.32
N/A
0.09
0.01
(0.03)
0.01
(0.02)
(0.04)
(0.17)
Rate Of Daily Change
0.9
1.02
1.0
1.03
1.01
0.98
1.02
0.99
0.96
0.99
Day Median Price
0.82
16.25
27.99
2.92
1.06
1.19
0.64
2.99
1.0
13.18
Price Action Indicator
(0.09)
1.06
(1.59)
0.02
0.015
(0.04)
0.025
(0.05)
(0.04)
(0.33)
Coefficient Of Variation
1321.54
2983.73
707.23
32098.43
723.7
(924.07)
(155,105)
1482.43
(781.95)
2346.16
Mean Deviation
4.93
2.95
9.58
3.61
2.02
2.58
5.99
5.56
2.77
3.39
Jensen Alpha
0.43
0.1
1.71
(0.44)
0.4547
(0.37)
(0.20)
0.4779
(0.67)
(0.1)
Total Risk Alpha
(0.65)
(0.51)
(0.16)
(0.71)
(0.07)
(0.94)
(1.17)
(0.67)
(1.13)
(0.50)
Sortino Ratio
0.076
0.0038
0.2719
(0.02)
0.1975
N/A
N/A
0.0638
N/A
0.0138
Downside Variance
46.22
20.1
62.38
23.2
6.47
N/A
N/A
41.05
N/A
24.38
Standard Deviation
8.48
4.25
16.07
4.76
4.54
3.61
7.65
7.91
4.01
4.54
Kurtosis
11.06
3.43
11.38
0.3388
37.76
2.74
0.1109
2.81
2.95
1.54
Potential Upside
7.84
8.79
20.63
9.48
3.06
5.22
13.95
17.06
6.2
8.35
Treynor Ratio
0.3612
0.4715
0.4684
0.0012
0.4372
1.76
(0.01)
1.32
(0.41)
0.0756
Maximum Drawdown
49.6
21.34
105.83
21.3
38.16
21.68
30.28
45.73
20.99
25.76
Variance
71.93
18.05
258.35
22.69
20.63
13.03
58.52
62.63
16.08
20.66
Market Risk Adjusted Performance
0.3712
0.4815
0.4784
0.0112
0.4472
1.77
8.0E-4
1.33
(0.40)
0.0856
Risk Adjusted Performance
0.0671
0.0339
0.1179
0.0108
0.1142
(0.08)
0.0085
0.0607
(0.09)
0.041
Skewness
2.43
(0.39)
2.96
0.2258
5.5
0.6886
0.287
1.03
0.4199
(0.42)
Semi Deviation
5.64
4.39
6.82
4.52
1.53
N/A
N/A
6.18
N/A
4.83
Information Ratio
0.0609
0.004
0.1336
(0.02)
0.1106
(0.14)
(0.02)
0.0516
(0.16)
0.015
Value At Risk
(11.11)
(5.34)
(10.89)
(8.36)
(2.88)
(6.37)
(12.70)
(11.25)
(5.34)
(6.74)
Expected Short fall
(6.46)
(2.92)
(12.82)
(3.86)
(3.19)
N/A
N/A
(6.45)
N/A
(3.30)
Downside Deviation
6.8
4.48
7.9
4.82
2.54
N/A
N/A
6.41
N/A
4.94
Semi Variance
31.82
19.29
46.53
20.45
2.34
N/A
N/A
38.16
N/A
23.34

Fresh Tracks Competition Performance Charts

Five steps to successful analysis of Fresh Tracks Competition

Fresh Tracks' competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Fresh Tracks Therapeutics in relation to its competition. Fresh Tracks' competition analysis typically involves several steps, including:
  • Identifying the key players in the market: This involves identifying the major competitors of Fresh Tracks in the market, both direct and indirect, as well as new entrants and disruptive technologies.
  • Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
  • Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Fresh Tracks' competitive landscape.
  • Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Fresh Tracks Therapeutics, and developing a strategy to address them.
  • Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your Fresh Tracks position

In addition to having Fresh Tracks in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Business Supplies Thematic Idea Now

Business Supplies
Business Supplies Theme
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Business Supplies theme has 24 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Business Supplies Theme or any other thematic opportunities.
View All  Next Launch
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.
You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.

Other Consideration for investing in Fresh Pink Sheet

If you are still planning to invest in Fresh Tracks Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Fresh Tracks' history and understand the potential risks before investing.
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Commodity Directory
Find actively traded commodities issued by global exchanges
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY